Current Issue May 2012, Vol. 30, No. 3

In This Issue

The Oncology Knowledge Assessment Test
May 2012 (Vol. 30 | No. 3 | Page 235)
Steven C. Campbell, Michael S. Cookson
- Full Text
- PDF (62 KB)
Update on the Society of Urologic Oncology fellowship programs
May 2012 (Vol. 30 | No. 3 | Pages 236-237)
Jeffrey M. Holzbeierlein
- Full Text
- PDF (77 KB)
The Outreach Committee of the Society of Urologic Oncology (SUO): Advancing the patient mission
May 2012 (Vol. 30 | No. 3 | Pages 238-239)
Cheryl T. Lee
- Full Text
- PDF (80 KB)
An update on targeted therapy in metastatic renal cell carcinoma
May 2012 (Vol. 30 | No. 3 | Pages 240-246)
Giuseppe Lombardi, Fable Zustovich, Martin Donach, Maurizia Dalla Palma, Ornella Nicoletto, Davide Pastorelli
Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy
May 2012 (Vol. 30 | No. 3 | Pages 247-251)
Martine Ploeg, Lambertus A.L.M. Kiemeney, Geert A. Smits, Henk Vergunst, Andre C. Viddeleer, Arno D.H. Geboers, Hans van Berkel, Erika van Boven, Katja K.H. Aben, J. Alfred Witjes

Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: Results from the UroScreen-Study
24 May 2012
Severine Banek, Christian Schwentner, Dirk Täger, Beate Pesch, Michael Nasterlack, Gabriele Leng, Katarzyna Gawrych, Nadine Bonberg, Georg Johnen, Mattias Kluckert, Georgios Gakis, Tilman Todenhöfer, Joerg Hennenlotter, Thomas Brüning, Arnulf Stenzl, UroScreen Study Group
Abstract: Background: UroScreen is a prospective study for early diagnosis of bladder cancer (BC) in chemical workers formerly exposed to aromatic amines, aimed to assess the performance of molecular ...
Health-related quality of life for men with prostate cancer—an evaluation of outcomes 12–24 months after treatment
21 May 2012
Stephen A. Brassell, Sally I. Elsamanoudi, Jennifer Cullen, Molly E. Williams, David G. McLeod
Abstract: Objective: To determine the health-related quality of life (HRQoL) impact of prostate cancer interventions at 2 years post-treatment, and between the 12- and 24-month interval, to better cha...
Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma
21 May 2012
Yeong-Chin Jou, Yuh-Shyan Tsai, Hsiao-Yen Hsieh, Syue-Yi Chen, Hsin-Tzu Tsai, Ko-Jung Chen, Shan-Tair Wang, Ai-Li Shiau, Chao-Liang Wu, Tzong-Shin Tzai
Abstract: Objectives: To determine the plasma levels of thymosin-α1 (TA1) and prothymosin-α (PTMA) proteins in renal cell carcinoma (RCC) or urothelial carcinoma (UC) patients, and explore the potenti...
No ischemia robotic partial nephrectomy: why and why not?
21 May 2012
Ronney Abaza
Robotic technology has increasingly allowed partial nephrectomy in minimally invasive fashion even for complex tumors. Performing such resections is typically performed with warm ischemia, but feasibi...
Clinical outcome in patients receiving systemic therapy for metastatic sarcomatoid renal cell carcinoma: A retrospective analysis☆
21 May 2012
Sumanta K. Pal, Jeremy O. Jones, Courtney Carmichael, Junmi Saikia, Joanne Hsu, Xueli Liu, Robert A. Figlin, Przemyslaw Twardowski, Clayton Lau
Abstract: Objectives: Sarcomatoid metastatic renal cell carcinoma (mRCC) represents an aggressive subset of disease, and a definitive therapeutic strategy is lacking. We seek to define outcomes associ...

View More Articles in Press...

On the Cover

New Issue Alert

Free Trial Issue

Journal Ranking

2010 Impact Factor: 3.172

Ranks 15th of 69 journals in the Urology & Nephrology category.

© 2011 Journal Citation Reports®, Thomson Reuters

Journal Access

Full-text articles are available from 1995 to the present. (The numbering gap between Volumes 7 and 21 results from a title merger.) Access to abstracts is complimentary. Access to full text is limited to Society of Urologic Oncology members as well as personal subscribers.

Activate Online Access

Publishing Information

Urologic Oncology: Seminars and Original Investigations is published by Elsevier for the Society of Urologic Oncology (SUO).

Access this journal onSciVerse ScienceDirect

Seminar Section

Environmental Exposures and Genitourinary Malignancies

NORM D. SMITH, M.D., GUEST EDITOR

Environmental Exposures and Genitourinary Malignancies Free

About SUO

The Society of Urologic Oncology (SUO) was created in 1984 to enable qualified members primarily interested in the care of patients with malignant genitourinary diseases to meet for the purpose of discussion, development, and implementation of ideas to improve care. The Society and its bylaws conform to the guidelines and bylaws of the American Urological Association (AUA).

About Urologic Oncology: Seminars and Original Investigations

Urologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology. This new journal combines the original research from Urologic Oncology: Seminars and Original Investigations with the comprehensive single topic overviews from Seminars in Urologic Oncology. The combined publication delivers timely clinical research and up-to-date comprehensive reviews of critical scientific relevance. Each issue comprises original articles and reviews including an in-depth Seminar examining a specific clinical dilemma. All articles are of significant interest to all clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.